Keros Therapeutics, Inc. (KROS) Earnings
Keros Therapeutics, Inc. is expected to report next earnings on November 4, 2026 (in NaN days), with a consensus EPS estimate of $-0.94. KROS has beaten EPS estimates in 6 of its last 12 reported quarters (average surprise -7.9% over the last four).
Next earnings
Nov 4, 2026in NaN days
EPS est $-0.94 · Revenue est $15M
Track record
Beat EPS in 6 of 12 quarters
Avg surprise -7.9% (last 4 quarters)
Earnings history
| Report date | EPS est | EPS actual | Surprise | Revenue | Rev. surprise |
|---|---|---|---|---|---|
| Aug 3, 2026 | $-1.34 | $-1.45 | -8.2% | — | — |
| May 14, 2026 | $-0.92 | $-1.21 | -31.5% | $367000 | -81.0% |
| Mar 4, 2026 | $-0.49 | $-0.86 | -75.5% | $385000 | -21.9% |
| Nov 5, 2025 | $-1.11 | $-0.18 | +83.8% | $14M | +289.4% |
| Aug 6, 2025 | $-1.14 | $-0.76 | +33.3% | $18M | +465.9% |
| Feb 26, 2025 | $-1.36 | $-1.14 | +16.2% | $3M | -86.3% |
| Feb 28, 2024 | $-1.38 | $-1.34 | +2.9% | $143000 | — |
| May 4, 2023 | $-1.13 | $-1.26 | -11.5% | — | — |
| Mar 3, 2023 | $-1.12 | $-1.09 | +2.7% | — | — |
| Nov 3, 2022 | $-1.26 | $-0.92 | +27.0% | — | — |
| Aug 4, 2022 | $-1.07 | $-1.13 | -5.6% | $100000 | — |
| May 5, 2022 | $-0.86 | $-1.01 | -17.4% | — | — |
Source: company filings + earnings calendar. For informational purposes only — not investment advice.